CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

It looks like Rad Power Bikes owners may soon have a more affordable path to upgrading to the company’s newer Safe Shield battery technology. In an email just sent out today, Rad Life Mobility ...

Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperforming stock price, the Wall Street Journal reported, citing people ...

May 17 (Reuters) - Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories (BIO.N), opens new tab, and plans ‌to push the company ...

Even with just its one front-facing antenna, when most radar detectors have two, the RAD 700i gives sufficient warnings of speed-measuring equipment up to a mile away. The RAD 700i has voice alerts in ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

If you've always wanted a radar detector but were turned off by the high cost, it's time to find a new excuse not to buy one. Cobra's RAD 480i has been the best-selling radar detector in the U.S. for ...

Chocolate bars made from lab-grown ingredients, rather than cocoa sourced from plantations, are no longer confined to science fiction. They are now a reality, with nearly a dozen such chocolate bars ...

Cellares reported that the first two patients have been dosed with Cabaletta Bio’s investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) manufactured on Cellares’ Cell Shuttle™ ...

Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a team of fewer than 10 ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6. The review extension comes after the company submitted additional data ...

BERKELEY, CA, March 10, 2026 (EZ Newswire) -- R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological platforms ...